| Meredith A Heberer, MD | |
|
4700 Las Vegas Blvd N, Nellis Afb, NV 89191-6600 | |
| (702) 653-3767 | |
| Not Available |
| Full Name | Meredith A Heberer |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 15 Years |
| Location | 4700 Las Vegas Blvd N, Nellis Afb, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538484456 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | AZ5717 (Arizona) | Secondary |
| 208600000X | Surgery | 53446 (Arizona) | Secondary |
| 208600000X | Surgery | 20580 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Henderson Hospital | Henderson, NV | Hospital |
| Spring Valley Hospital Medical Center | Las vegas, NV | Hospital |
| Centennial Hills Hospital Medical Center | Las vegas, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Las Vegas Medical Group Llc | 6800118522 | 43 |
News Archive
Protalix BioTherapeutics, Inc., announced today positive preliminary data from the first 15 patients that completed the Company's nine month, worldwide, multi-center, open-label, switchover trial of taliglucerase alfa for the treatment of Gaucher disease under a protocol cleared by the U.S. Food and Drug Administration (FDA). The data indicate that patients can safely be switched to taliglucerase alfa from imiglucerase (Cerezyme®).
A new Finnish study suggests that type 1 diabetes may in part be caused by a novel subset of immune cells. This is because these cells, called peripheral T helper cells, are found to circulate at a higher rate in children with type 1 diabetes of recent onset, as well as in healthy children who later develop the condition.
In the final event leading to the development of Type 2 diabetes, the pancreas loses its ability to secrete insulin and clear glucose from the blood. Preventing this breakdown in insulin secretion is a key goal in the fight to reduce the burden of a disease that afflicts an estimated 29 million people in the United States.
"Medicare fraud runs rampant in Miami-Dade" while federal experts examine how the crime spreads among different ethnic communities in different cities, The Associated Press/Miami Herald reports
The Pediatric Interventional Cardiac Symposium (PICS) & Adult Interventional Cardiac Symposium (AICS) Lifetime Achievement Award for 2007 was recently presented to John P. Cheatham, MD, Co-Director of The Heart Center at Columbus Children's Hospital and Professor of Pediatrics & Internal Medicine at The Ohio State University College of Medicine.
› Verified 8 days ago
| Entity Name | Las Vegas Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447656988 PECOS PAC ID: 6800118522 Enrollment ID: O20141209001376 |
News Archive
Protalix BioTherapeutics, Inc., announced today positive preliminary data from the first 15 patients that completed the Company's nine month, worldwide, multi-center, open-label, switchover trial of taliglucerase alfa for the treatment of Gaucher disease under a protocol cleared by the U.S. Food and Drug Administration (FDA). The data indicate that patients can safely be switched to taliglucerase alfa from imiglucerase (Cerezyme®).
A new Finnish study suggests that type 1 diabetes may in part be caused by a novel subset of immune cells. This is because these cells, called peripheral T helper cells, are found to circulate at a higher rate in children with type 1 diabetes of recent onset, as well as in healthy children who later develop the condition.
In the final event leading to the development of Type 2 diabetes, the pancreas loses its ability to secrete insulin and clear glucose from the blood. Preventing this breakdown in insulin secretion is a key goal in the fight to reduce the burden of a disease that afflicts an estimated 29 million people in the United States.
"Medicare fraud runs rampant in Miami-Dade" while federal experts examine how the crime spreads among different ethnic communities in different cities, The Associated Press/Miami Herald reports
The Pediatric Interventional Cardiac Symposium (PICS) & Adult Interventional Cardiac Symposium (AICS) Lifetime Achievement Award for 2007 was recently presented to John P. Cheatham, MD, Co-Director of The Heart Center at Columbus Children's Hospital and Professor of Pediatrics & Internal Medicine at The Ohio State University College of Medicine.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Meredith A Heberer, MD 4700 Las Vegas Blvd N, Nellis Afb, NV 89191-6600 Ph: (702) 653-3767 | Meredith A Heberer, MD 4700 Las Vegas Blvd N, Nellis Afb, NV 89191-6600 Ph: (702) 653-3767 |
News Archive
Protalix BioTherapeutics, Inc., announced today positive preliminary data from the first 15 patients that completed the Company's nine month, worldwide, multi-center, open-label, switchover trial of taliglucerase alfa for the treatment of Gaucher disease under a protocol cleared by the U.S. Food and Drug Administration (FDA). The data indicate that patients can safely be switched to taliglucerase alfa from imiglucerase (Cerezyme®).
A new Finnish study suggests that type 1 diabetes may in part be caused by a novel subset of immune cells. This is because these cells, called peripheral T helper cells, are found to circulate at a higher rate in children with type 1 diabetes of recent onset, as well as in healthy children who later develop the condition.
In the final event leading to the development of Type 2 diabetes, the pancreas loses its ability to secrete insulin and clear glucose from the blood. Preventing this breakdown in insulin secretion is a key goal in the fight to reduce the burden of a disease that afflicts an estimated 29 million people in the United States.
"Medicare fraud runs rampant in Miami-Dade" while federal experts examine how the crime spreads among different ethnic communities in different cities, The Associated Press/Miami Herald reports
The Pediatric Interventional Cardiac Symposium (PICS) & Adult Interventional Cardiac Symposium (AICS) Lifetime Achievement Award for 2007 was recently presented to John P. Cheatham, MD, Co-Director of The Heart Center at Columbus Children's Hospital and Professor of Pediatrics & Internal Medicine at The Ohio State University College of Medicine.
› Verified 8 days ago
Mr. Kyle A Mecham, D.O. Surgery Medicare: Medicare Enrolled Practice Location: 4700 Las Vegas Blvd N, Nellis Afb, NV 89191 Phone: 702-653-2273 | |
Dr. Benjamin Monson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4700 Las Vegas Blvd N, Nellis Afb, NV 89191 Phone: 702-653-3050 | |
William Pinette, MD Surgery Medicare: Medicare Enrolled Practice Location: 4700 Las Vegas Blvd N, Nellis Afb, NV 89191 Phone: 702-653-2273 | |
Dr. Kevin Dunn, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 4700 Las Vegas Blvd N, Nellis Afb, NV 89191 Phone: 702-653-2791 | |
Dr. Travis Atkinson Arnold-lloyd, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4700 Las Vegas Blvd N, Nellis Afb, NV 89191 Phone: 702-653-2273 Fax: 314-362-5743 | |
Danielle M Dombrowski, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 4700 Las Vegas Blvd N, Nellis Afb, NV 89191 Phone: 702-653-2273 | |
Keith A Berry, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 4700 Las Vegas Blvd N, Nellis Afb, NV 89191 Phone: 702-653-2273 |